Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term 'Kidney and heart' refers to two primary organ systems in the human body rather than a specific molecular target such as a receptor, enzyme, or ion channel. The kidneys are essential for filtering waste products from the blood and maintaining electrolyte balance, while the heart serves as the central pump of the cardiovascular system. While these organs are the sites of action for numerous therapeutic classes—such as SGLT2 inhibitors in the kidney and beta-blockers in the heart—the organs themselves do not constitute a singular, discrete biochemical target for drug discovery. In clinical medicine, the interplay between these two systems is often discussed in the context of cardiorenal syndrome, where dysfunction in one organ leads to dysfunction in the other. Because 'Kidney and heart' is an anatomical and physiological classification rather than a molecular one, it is considered an incorrect entry for a specific therapeutic target molecule.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kidney and heart.